scorecardresearch
Monday, September 8, 2025
TopicVaccine

Topic: Vaccine

Vaccine manufacturer Indian Immunologicals Ltd to launch dengue vaccine by January 2026

According to NCDC, there was a 333% surge in dengue cases from 2020 to 2021 and a 21% rise in number of cases between 2021 and 2022.

Blob that created history — tracking six-decade quest for respiratory syncytial virus vaccine

GlaxoSmithKline’s vaccine for respiratory syncytial virus was approved by The Medicines and Healthcare products Regulatory Agency in Britain on Monday.

Hope for chikungunya vaccine: French drugmaker reports 99% immune response in Phase 3 trial

Trial of live-attenuated vaccine VLA1553 was conducted in US, with high seroprotection rates observed in participants up to 180 days after vaccination. Study published in 'The Lancet'.

‘Very promising’: World’s first vaccine, tested in Vietnam, against African swine fever nears approval

After decades of failed attempts due to the complexity of the virus, two vaccines co-developed by US scientists being tested in large pilot schemes by Vietnamese companies, WHO said.

People lost faith in childhood vaccines during Covid pandemic, says UNICEF report

The data was a 'worrying warning signal' of rising vaccine hesitancy amid misinformation, dwindling trust in governments and political polarisation, UNICEF said.

Phase 2 trial of Moderna-Merck’s personalised cancer vaccine shows positive results

Treatment with Moderna’s experimental mRNA vaccine in combination with Merck’s immunotherapy technology reduced risk of cancer recurrence or death by 44%, the companies said.

Covid, low awareness, vaccine hesitancy — why Mumbai’s reeling from a measles outbreak

From 92% vaccination in 2019-20, the number of those given 1st dose dropped to 74% in 2021-22. This year, only 43% children in Mumbai had received 1st dose till October.

India vaccine against cervical cancer to be launched Thursday, ‘will combat global shortage’

The Serum Institute of India & Department of Biotechnology are set to launch the country's first indigenously developed Quadrivalent Human Papillomavirus vaccine against cervical cancer.

After Covid, mRNA vaccine for cancer? US researchers report initial success against melanoma

Mice treated with the mRNA vaccine, delivered like ones for Covid, showed reduction in tumours & long-term immune memory, says study by Tufts University researchers published in PNAS.

How ICAR grew 50 generations of virus over 1.5 years to develop lumpy skin disease vaccine

Lumpi-ProVac, a vaccine developed by 2 Indian Council of Agricultural Research institutes, was found effective in preventing lumpy skin disease in cattle & is ready for commercial launch.

On Camera

Punjab floods are a test for parties. They must act together and fast

PM Modi’s silence on Punjab floods while he tweets about earthquakes in Afghanistan and floods in Pakistan was deafening. A phone call to CM Mann was a small consolation, but people wanted public empathy.

Punjab’s paddy farmers are staring at big losses. Why flood impact may spill out of India’s rice bowl

As devastated farmers begin to come to terms with the fallout, 4 lakh hectares of land under paddy cultivation across state is flooded. Punjab is among the biggest contributors to PDS.

Army chief weighs in on theaterisation, says it is inevitable and need of the hour

New Delhi: Army chief General Upendra Dwivedi has strongly backed the idea of theaterisation, saying it is inevitable and the need of the hour. Speaking...

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?